OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
SARS-CoV-2 BA.4 infection triggers more cross-reactive neutralizing antibodies than BA.1
Simone I. Richardson, Thopisang Motlou, Mieke A. van der Mescht, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 6
Simone I. Richardson, Thopisang Motlou, Mieke A. van der Mescht, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 6
Showing 6 citing articles:
Analysis of anti-SARS-CoV-2 Omicron-neutralizing antibody titers in different vaccinated and unvaccinated convalescent plasma sources
David J. Sullivan, Massimo Franchini, Michael J. Joyner, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 78
David J. Sullivan, Massimo Franchini, Michael J. Joyner, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 78
Impact of SARS-CoV-2 exposure history on the T cell and IgG response
Roanne Keeton, Marius B. Tincho, Akiko Suzuki, et al.
Cell Reports Medicine (2022) Vol. 4, Iss. 1, pp. 100898-100898
Open Access | Times Cited: 41
Roanne Keeton, Marius B. Tincho, Akiko Suzuki, et al.
Cell Reports Medicine (2022) Vol. 4, Iss. 1, pp. 100898-100898
Open Access | Times Cited: 41
Exposure to BA.4/5 S protein drives neutralization of Omicron BA.1, BA.2, BA.2.12.1, and BA.4/5 in vaccine-experienced humans and mice
Alexander Muik, Bonny Gaby Lui, Maren Bacher, et al.
Science Immunology (2022) Vol. 7, Iss. 78
Open Access | Times Cited: 28
Alexander Muik, Bonny Gaby Lui, Maren Bacher, et al.
Science Immunology (2022) Vol. 7, Iss. 78
Open Access | Times Cited: 28
Clinical development of variant-adapted BNT162b2 COVID-19 vaccines: the early Omicron era
Shanti Pather, Alexander Muik, Ruben Rizzi, et al.
Expert Review of Vaccines (2023) Vol. 22, Iss. 1, pp. 650-661
Open Access | Times Cited: 15
Shanti Pather, Alexander Muik, Ruben Rizzi, et al.
Expert Review of Vaccines (2023) Vol. 22, Iss. 1, pp. 650-661
Open Access | Times Cited: 15
Beta-variant recombinant booster vaccine elicits broad cross-reactive neutralization of SARS-CoV-2 including Omicron variants
Delphine Planas, Lin Peng, Lingyi Zheng, et al.
Heliyon (2024) Vol. 10, Iss. 5, pp. e27033-e27033
Open Access | Times Cited: 1
Delphine Planas, Lin Peng, Lingyi Zheng, et al.
Heliyon (2024) Vol. 10, Iss. 5, pp. e27033-e27033
Open Access | Times Cited: 1
Exposure to BA.4/BA.5 Spike glycoprotein drives pan-Omicron neutralization in vaccine-experienced humans and mice
Alexander Muik, Bonny Gaby Lui, Maren Bacher, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 5
Alexander Muik, Bonny Gaby Lui, Maren Bacher, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 5
